Philips' localization strategy is fully accelerated, and high-end magnetic resonance realizes "Made in China" Philips' domestically produced Ingenia Ambition officially launched in China through NMPA certification

Suzhou, China - Recently, Philips (China) announced that the high-end MRI Ingenia Ambition produced by the Philips (Suzhou) Medical Imaging Base has passed the National Medical Products Administration (NMPA) certification and will be officially launched in the Chinese market. In recent years, in the field of precise diagnosis, Philips has achieved local R&D and manufacturing of ultrasound, CT, MR and other products in the Chinese market, combined with advanced informatics and intelligent systems, focused on the clinical needs of local customers, and provided integrated local solution. The localization of Ingenia Ambition will further enrich Philips' "localized" product portfolio in the Chinese market, and gradually move towards "high-end intelligent manufacturing".

Chen Shengyu, Senior Vice President of Philips Greater China and General Manager of Precision Diagnosis Business Group, said: "China is Philips' second largest market in the world. Philips is comprehensively promoting the process of 'localization' in China and building an 'end-to-end' complete value chain. Covering all aspects of R&D, manufacturing, market access, sales, service, etc., to better serve the Chinese market with a faster speed, a more accurate perspective, and a more optimized way. The approval of the domestic Ingenia Ambition is our active integration. The best evidence that global and local resources empower 'Made in China'."

The Ingenia Ambition will be launched in China in 2020, and a number of industry-leading innovative technologies it has deployed have also been realized in the domestic Ingenia Ambition.

The completely sealed Blueseal magnet technology completely encapsulates 7 liters of liquid helium in a one-shot cavity, ensuring that helium will not leak out during the entire service cycle of the device, and there is no need to fill new liquid helium. The design of no quench tube makes it avoid the risk of "quench" from the root, and reduces the cost of equipment management, installation and maintenance for medical institutions; at the same time, it reduces the dependence on liquid helium supply, improves energy efficiency, and protects the earth's helium resources for sustainable development.

Another feature of the Ingenia Ambition MRI is that it is "small, light, and flexible" and can be installed on any floor, helping medical institutions to solve site constraints more flexibly. At the same time, this feature is also applicable to hospitals with a long history, to solve the problem of site limitations in the location and renovation of the magnetic resonance machine room. The advent of Ingenia Ambition makes the use of magnetic resonance not limited to the radiology department, and makes it possible for magnetic resonance to enter specific medical scenarios such as operating rooms, radiotherapy, physical examinations, inpatient departments, and shelters, which greatly expands the application of magnetic resonance. scene and field.

Ingenia Ambition Magnetic Resonance is also equipped with a full-body full-sequence compressed sensing technology platform. On the premise of ensuring image quality, the overall inspection efficiency is greatly improved, allowing medical institutions to provide MRI scans for more patients within a limited time, saving money The waiting time of patients has greatly alleviated the pain points of difficult hospital appointments, long queues, and slow examinations. The compressed sensing technology platform not only shows excellent clinical value, but also makes outstanding contributions in scientific research. As an important scientific research platform in the field of Philips magnetic resonance, it has played a significant role in related scientific research projects in the heart, abdomen and other parts.

The successful launch of the localized Ingenia Ambition MRI in China will not only help improve the hospital's ability to provide high-quality medical services, improve the efficiency of diagnosis and treatment, and improve patient satisfaction, but also further strengthen the in-depth integration of "production, education, research and application", and realize Philips "in the China, for China's commitment to take root, and jointly contribute to the realization of the grand goal of Healthy China 2030.